ScanSource Q3 sales rise 8.8% to $766.8 million; raises free cash flow outlook
ScanSource reported fiscal third-quarter 2026 net sales of $766.8 million, up 8.8% year over year, and GAAP diluted EPS of $0.78 versus $0.74. GAAP net income fell 3.1% to $16.9 million, and adjusted EBITDA rose 1.6% to $35.6 million, with its margin down to 4.65% from 4.97%. The company reaffirmed its net sales and adjusted EBITDA outlook for fiscal 2026 and raised its free cash flow outlook to at least $90 million.
Key points
- Diluted EPS was $0.78 GAAP versus $0.74 a year earlier, and $0.94 non-GAAP versus $0.86, up 9.3%.
- GAAP net income was $16.9 million, down 3.1%; adjusted EBITDA was $35.6 million, up 1.6%, with margin of 4.65% versus 4.97%.
- Fiscal 2026 outlook reaffirmed: net sales of $3.0 billion to $3.1 billion and adjusted EBITDA of $140 million to $150 million.
- Free cash flow outlook raised to at least $90 million from at least $80 million; share repurchases totaled $71.4 million in the first nine months of fiscal 2026.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.